VAERS Explorer
Back to explore

Report #2873911

Received Nov 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
58 yrs
State
—
Recovered
Not recovered
Vaccinated
—
Onset
May 1, 2021
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNA2——

Symptoms (5)

COVID-19Drug hypersensitivityJoint swellingMetastases to boneProstate cancer stage IV

Symptom narrative

Prostate cancer stage 4/turbo cancer; The prostate cancer was usually pretty slow, it grew in a year or two and went to the bones; highly allergic to the spike protein; Covid-19; Ankle swelled up/Chronic inflammation; This spontaneous case was reported by a consumer and describes the occurrence of PROSTATE CANCER STAGE IV (Prostate cancer stage 4/turbo cancer) and METASTASES TO BONE (The prostate cancer was usually pretty slow, it grew in a year or two and went to the bones) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for Product used for unknown indication: VARICELLA ZOSTER VACCINE. Past adverse reactions to the above products included No adverse effect with VARICELLA ZOSTER VACCINE. On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced JOINT SWELLING (Ankle swelled up/Chronic inflammation). In December 2021, the patient experienced COVID-19 (Covid-19). On an unknown date, the patient experienced PROSTATE CANCER STAGE IV (Prostate cancer stage 4/turbo cancer) (seriousness criterion medically significant), METASTASES TO BONE (The prostate cancer was usually pretty slow, it grew in a year or two and went to the bones) (seriousness criterion medically significant) and DRUG HYPERSENSITIVITY (highly allergic to the spike protein). At the time of the report, PROSTATE CANCER STAGE IV (Prostate cancer stage 4/turbo cancer) had not resolved, METASTASES TO BONE (The prostate cancer was usually pretty slow, it grew in a year or two and went to the bones), COVID-19 (Covid-19) and DRUG HYPERSENSITIVITY (highly allergic to the spike protein) outcome was unknown and JOINT SWELLING (Ankle swelled up/Chronic inflammation) had resolved. No concomitant medications were provided. It was reported that back in 2021, the patient got 2 Moderna shots. It was reported that a month later the patient's ankle swelled up almost chronically in nature and lasted about a year or so. It was reported that in late May-2021 his left ankle swelled up mainly the left ankle was swollen, and then it flipped to the right ankle, quarter by quarter the swelling would go away and then a month later it would come back and then go away and come back. It was reported that it was off and on chronic inflammation for 2 years and then it led to cancer. It was stage 4 prostate cancer. The oncologist called it turbo cancer, and you never see anything like it. The prostate cancer was usually slow, however at 62 years of age, it grew in a year or two and went to the bones. The patient caught COVID in Dec-2021, and his ankles blew up again and he caught COVID again sometime in mid-year of 2022 (maybe early spring) and his ankles swelled again. It was reported that he did not have an episode in a few years, and he believed that he was highly allergic to the spike protein. The reporter states that in the past year he had gotten the shingles vaccine. No other details provided. No treatment medication was provided.; Reporter's Comments: Causality for Prostate cancer stage IV and Metastases to bone has been assessed as not related, due to lack of biological plausibility. The benefit-risk relationship of product is not affected by this report.